Regulus Therapeutics
RGLS
#6949
Rank
ยฃ0.42 B
Marketcap
ยฃ6.13
Share price
0.00%
Change (1 day)
414.18%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: ยฃ0.42 Billion

As of December 2025 Regulus Therapeutics has a market cap of ยฃ0.42 Billion. This makes Regulus Therapeutics the world's 6949th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ0.42 B427.59%
2024ยฃ80.38 M295.61%
2023ยฃ20.31 M6.54%
2022ยฃ19.07 M-44.02%
2021ยฃ34.06 M-45.84%
2020ยฃ62.89 M340.89%
2019ยฃ14.26 M120.67%
2018ยฃ6.46 M-91.92%
2017ยฃ79.99 M-17.11%
2016ยฃ96.5 M-68.86%
2015ยฃ0.30 B-38.54%
2014ยฃ0.50 B169.35%
2013ยฃ0.18 B34.04%
2012ยฃ0.13 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
ยฃ73.35 B 17,196.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
ยฃ90.75 B 21,299.92%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ19.96 B 4,607.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ209.88 B 49,392.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
ยฃ45.43 B 10,613.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ0.12 B-70.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ79.69 B 18,691.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.23 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA